UnitedHealth Group delivered strong second-quarter results, surpassing revenue and earnings expectations and raising their full-year earnings guidance. While acknowledging higher medical costs due to increased care utilization among seniors and in behavioral health, the management expressed confidence in their ability to manage these trends and maintain growth. The company's robust performance and positive outlook are likely to positively influence the stock price in the short term.

[1]